Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-25 @ 4:45 PM
Study NCT ID:
NCT06743503
Status:
RECRUITING
Last Update Posted:
2025-09-18
First Post:
2024-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Sponsor:
Nanjing IASO Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2028-05-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-10
First Submit QC Date:
None
Study First Post Date:
2024-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-12
Last Update Post Date:
2025-09-18
Last Update Post Date Type:
ESTIMATED